Literature DB >> 19259815

Hospitalizations for inflammatory bowel disease among US military veterans 1975-2006.

Amnon Sonnenberg1, Peter A Richardson, Neena S Abraham.   

Abstract

BACKGROUND: The Department of Veterans Affairs (VA) is the largest healthcare system in the United States. The VA database was used to analyze patterns of hospitalization for inflammatory bowel disease (IBD) among US military veterans.
METHODS: The study used the VA Patient Treatment File (PTF) between 1975 and 2006. Each hospital record extracted from the PTF included diagnosis, patient age, and ethnicity. Patient age was analyzed in three age groups: 0-44, 45-64, and 65+. Patient ethnicity was analyzed by two broad categories as white and nonwhite.
RESULTS: Among veterans, Crohn's disease was more common than ulcerative colitis and both diseases were more common in whites than in nonwhites. During the past 30 years, the age distributions of both diseases have shifted towards older patients who have come to represent an increasingly larger fraction of patients with Crohn's disease, as well as ulcerative colitis. Hospitalization rates for inflammatory bowel disease among whites recently declined, while most rates among nonwhites continued to rise throughout the observation period.
CONCLUSION: The present study revealed a time-dependent shift towards older ages in the age distribution of IBD among hospitalized veterans. These changes, which have been observed similarly in other US statistics, may reflect a birth-cohort phenomenon underlying the long-term time trends of IBD.

Entities:  

Mesh:

Year:  2009        PMID: 19259815     DOI: 10.1007/s10620-009-0764-x

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  13 in total

1.  Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences.

Authors:  Edward V Loftus
Journal:  Gastroenterology       Date:  2004-05       Impact factor: 22.682

2.  Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000.

Authors:  Conor G Loftus; Edward V Loftus; W Scott Harmsen; Alan R Zinsmeister; William J Tremaine; L Joseph Melton; William J Sandborn
Journal:  Inflamm Bowel Dis       Date:  2007-03       Impact factor: 5.325

3.  Birth-cohort phenomenon in the time trends of mortality from ulcerative colitis.

Authors:  F Delcò; A Sonnenberg
Journal:  Am J Epidemiol       Date:  1999-08-15       Impact factor: 4.897

4.  Crohn's disease among ethnic groups in a large health maintenance organization.

Authors:  J H Kurata; S Kantor-Fish; H Frankl; P Godby; C M Vadheim
Journal:  Gastroenterology       Date:  1992-06       Impact factor: 22.682

5.  Trends in incidence rates of ulcerative colitis and Crohn's disease.

Authors:  B M Calkins; A M Lilienfeld; C F Garland; A I Mendeloff
Journal:  Dig Dis Sci       Date:  1984-10       Impact factor: 3.199

6.  Trends in hospitalization rates for inflammatory bowel disease in the United States.

Authors:  Meenakshi Bewtra; Chinyu Su; James D Lewis
Journal:  Clin Gastroenterol Hepatol       Date:  2007-03-26       Impact factor: 11.382

7.  Time trends of physician visits for Crohn's disease and ulcerative colitis in the United States, 1960-2006.

Authors:  Amnon Sonnenberg; Joanne Chang
Journal:  Inflamm Bowel Dis       Date:  2008-02       Impact factor: 5.325

8.  An epidemiologic study of inflammatory bowel disease in Rochester, New York. Hospital incidence.

Authors:  S P Stowe; S R Redmond; J M Stormont; A N Shah; L N Chessin; H L Segal; W Y Chey
Journal:  Gastroenterology       Date:  1990-01       Impact factor: 22.682

9.  Geographic variation of inflammatory bowel disease within the United States.

Authors:  A Sonnenberg; D J McCarty; S J Jacobsen
Journal:  Gastroenterology       Date:  1991-01       Impact factor: 22.682

10.  Epidemiology of inflammatory bowel disease in a defined northern California population.

Authors:  R A Hiatt; L Kaufman
Journal:  West J Med       Date:  1988-11
View more
  7 in total

1.  Secular trends in hospitalization for IBD: the ecological niche.

Authors:  Meenakshi Bewtra; James D Lewis
Journal:  Dig Dis Sci       Date:  2009-04-28       Impact factor: 3.199

Review 2.  Challenges in designing a national surveillance program for inflammatory bowel disease in the United States.

Authors:  Millie D Long; Susan Hutfless; Michael D Kappelman; Hamed Khalili; Gilaad G Kaplan; Charles N Bernstein; Jean Frederic Colombel; Corinne Gower-Rousseau; Lisa Herrinton; Fernando Velayos; Edward V Loftus; Geoffrey C Nguyen; Ashwin N Ananthakrishnan; Amnon Sonnenberg; Andrew Chan; Robert S Sandler; Ashish Atreja; Samir A Shah; Kenneth J Rothman; Neal S Leleiko; Renee Bright; Paolo Boffetta; Kelly D Myers; Bruce E Sands
Journal:  Inflamm Bowel Dis       Date:  2014-02       Impact factor: 5.325

3.  The incidence and prevalence of inflammatory bowel disease among U.S. veterans: a national cohort study.

Authors:  Jason K Hou; Jennifer R Kramer; Peter Richardson; Minghua Mei; Hashem B El-Serag
Journal:  Inflamm Bowel Dis       Date:  2013-04       Impact factor: 5.325

4.  Demographic characteristics of hospitalized IBD patients.

Authors:  Amnon Sonnenberg
Journal:  Dig Dis Sci       Date:  2009-11       Impact factor: 3.199

5.  Time trend analysis and demographic features of inflammatory bowel disease in Tehran.

Authors:  Hedieh Balaii; Hamid Asadzadeh Aghdaei; Alma Farnood; Manijeh Habibi; Amir Ali Mafi; Farzad Firouzi; Afsaneh Sharifian; Shabnam Shahrokh; Farhad Lahmi; Homayoun Zojaji; Nosratollah Naderi; Mohammad Reza Zali
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2015

6.  Infection, Inflammation and Healing in Zebrafish: Intestinal Inflammation.

Authors:  Lindsay Marjoram; Michel Bagnat
Journal:  Curr Pathobiol Rep       Date:  2015-06-01

7.  Retrospective cohort study of anti-tumor necrosis factor agent use in a veteran population.

Authors:  Mark Bounthavong; Nermeen Madkour; Rashid Kazerooni
Journal:  PeerJ       Date:  2014-05-22       Impact factor: 2.984

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.